Persistence of MR3 in Chronic Myeloid Leukemia (CML) After a 2nd Stop of TKI Treatment
Condition(s):CML, RelapsedLast Updated:June 29, 2018Unknown status
Hide Studies Not Open or Pending
Condition(s):CML, RelapsedLast Updated:June 29, 2018Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:November 2, 2020Unknown status
Condition(s):Chronic Myelogenous LeukemiaLast Updated:February 23, 2017Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:May 11, 2016Unknown status
Condition(s):Chronic Myeloid LeukemiaLast Updated:March 3, 2009Available
Condition(s):Chronic Myeloid Leukemia; Minimal Residual DiseaseLast Updated:August 7, 2012Completed
Condition(s):Chronic Myeloid Leukemia, Chronic PhaseLast Updated:April 4, 2023Active, not recruiting
Condition(s):Chronic Myeloid LeukemiaLast Updated:June 21, 2022Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:September 25, 2017Completed
Condition(s):Chronic Myeloid LeukemiaLast Updated:June 20, 2006Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.